Article Details

Inovio Pharmaceuticals (NASDAQ:INO) Downgraded to Market Perform at Oppenheimer

Retrieved on: 2022-05-11 13:22:25

Tags for this article:

Click the tags to see associated articles and topics

Inovio Pharmaceuticals (NASDAQ:INO) Downgraded to Market Perform at Oppenheimer. View article details on hiswai:

Excerpt

WINTON GROUP Ltd now owns 31,567 shares of the biopharmaceutical company's stock worth $158,000 after acquiring an additional 3,519 shares in the last ...

Article found on: www.defenseworld.net

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up